Tissue Processing Systems Market is expected to reach US$ 493.76 million in 2027

by Sameer Joshi or 21-Feb-2021
     Request For Sample

Report : Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Tissue Transfer Processors and Fluid Transfer Processors), Volume (Small Volume Processors, Medium Volume Processors, and Large volume processors), and End User (Hospitals, Pharmaceutical Companies, Research laboratories, and Others) and Geography

Introduction of Innovative Products to be Prominent Trend in Tissue Processing Systems Market
 
According to our new research study of “Tissue Processing Systems Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Volume, and End User,” the market is expected to reach US$ 493.76 million in 2027 from US$ 335.78 million in 2019; it is estimated to grow at a CAGR of 5.1%from 2020 to 2027. The report highlights trends prevailing in the global tissue processing systems market, and drivers and hindrances pertaining to the market growth.
 
Many players operating in tissue processing systems market are developing and launching new products. The new product launch strategy helps the companies to expand their geographic reach and capacity to cater to a large number of customers. In October 2016, US-based Sakura Finetek launched Tissue-Tek VIP 6 AI—the latest generation of the gold standard VIP Tissue Processor. The Tissue-Tek VIP 6 AI offers next-level reliability and safety compared to the Tissue-Tek VIP processors, and it is a great choice for high-quality tissue processing, which enables easy and accurate diagnosis. Similarly, Milestone Medical, headquartered in Italy, launched its MAGNUS tissue processor at the 2019 Chinese Society of Pathology meeting in Zhengzhou; the MAGNUS is a patented hybrid tissue processing technology that does not require paraffin transfers, which saves time and potential blockages. MAGNUS runs urgent biopsies in fully automated, short, and continuous loading processes. Such developments and launches of new products are likely to favor the market growth in the coming years.
 
The global tissue processing systems market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. In North America, the US is the largest market for tissue processing systems. The growth of the region is attributed to the presence of key market players and their product development efforts. In addition, the escalating prevalence of cancer is further contributes to the tissue processing systems market growth in North America.
 
Agilent Technologies, Inc., Biogenex Laboratories, Sakura FinetekUsa, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Ag, Avantor, Milestone Medical, Leica Biosystems (Danaher Corporation), and Miltenyi Biotec are among the key companies in the tissue processing systems market. 
 
The report analyzes tissue processing systems market as follows:
 
By Product
  • Tissue Transfer Processors
  • Fluid Transfer Processors
By Volume
  • Small Volume Processors
  • Medium Volume Processors
  • Large Volume Processors 
By End User 
  • Hospitals
  • Pharmaceutical Companies
  • Research Laboratories 
  • Others
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America   
 
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876

Email Id: sales@reportsweb.com